Does oxidative stress drive fatigue and heightened pain signaling?

Oxidative stress is established as a central driver of fatigue and chronic pain, operating through a complex interplay of bioenergetic failure and neuroinflammation. In individuals over age 60, these processes may be particularly relevant due to the accumulation of age-related cellular damage and a natural decline in endogenous antioxidant defenses.

Clinical and effectiveness evidence

Research indicates that biomarkers of oxidative stress—such as malondialdehyde (MDA) and 8-hydroxy-2'-deoxyguanosine (8-OHdG)—correlate significantly with both pain intensity and reduced quality of life. In conditions characterized by nociplastic pain, such as fibromyalgia, patients frequently exhibit deficiencies in key antioxidants like Coenzyme Q10 (CoQ10) and Superoxide Dismutase (SOD), which are strongly tied to the severity of fatigue. Studies show that elevated reactive oxygen species (ROS) levels lower the activation threshold of peripheral nociceptors and induce central sensitization by activating glial cells (microglia and astrocytes) in the dorsal horn, sustaining chronic pain states.

Mechanistic explanations

The relationship between oxidative stress, fatigue, and pain is driven by specific molecular pathways:

• Mitochondrial Impairment: ROS directly target electron transport chain (ETC) complexes I and III and ATP synthase. This leads to lipid peroxidation of cardiolipin in the inner mitochondrial membrane, destabilizing OXPHOS supercomplexes and dissipating the mitochondrial membrane potential. The resulting drop in ATP production creates a systemic energy deficit manifested as fatigue.
• Inflammatory Amplification: Oxidative stress activates key pro-inflammatory nodes, including NF-κB and the NLRP3 inflammasome. This triggers the release of cytokines such as IL-1β, TNF-α, and IL-6.
• Feed-forward Loops: A self-sustaining cycle often develops where ROS-induced inflammation recruits enzymes like NADPH oxidases to generate further ROS. This is further exacerbated by the senescence-associated secretory phenotype (SASP), which maintains neuroimmune signaling and heightens pain sensitivity through chronic neuroinflammation.

Bottom line

Oxidative stress contributes to fatigue by causing mitochondrial bioenergetic collapse and heightens pain through the amplification of inflammatory pathways and central sensitization. Managing oxidative balance is a critical target for addressing the dual burden of chronic pain and energy depletion.